Parents Want Honesty About Child's Diagnosis, Says New Study

Regardless of the prognosis, parents of children with cancer prefer doctors to be open and honest, according to a new study.

"Providing families with a full explanation of the likely course of a disease is critical to helping them plan and have reasonable expectations about the outcome of treatment," says study leader Dr. Jonathan Marron, of Dana-Farber/Boston Children's Cancer and Blood Disorders Center.

Researchers asked 353 parents of children newly diagnosed with cancer about their discussions with their child's doctors. They wanted to know whether those conversations had a positive or a negative effect.

Parents whose children were given poor prognoses said that honesty from the doctors resulted in greater peace of mind for them. It also helped them develop trust in the physician.

Being given more information, even when bad, did not lead to widespread anxiety, depression or loss of hope compared with parents who were given less information, according to the findings.

"Most agree that patients and families should know as much about their diagnosis, treatment, and prognosis that physicians can give them," Marron said in a news release from the American Society of Clinical Oncology (ASCO). "At the same time, data have suggested that some oncologists are reluctant to discuss the details of prognosis with patients and their families out of concern that it might cause unnecessary anxiety and lead to depression. Our study suggests that such concerns are largely unwarranted."

These findings--scheduled to be presented at the end of May at the annual meeting of the American Society of Clinical Oncology in Chicago--should be considered preliminary until published in a peer-reviewed medical journal.

Source: ASCO

Photo by Eaglebrook School

More Articles

More Articles

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Since so many chemotherapy agents can affect a patient’s sex drive and fertility, thinking about these issues prior...

Secondary cancers are cancers that develop as a result of chemotherapy and/or...

One of the greatest fears of lymphoma survivors is that they’ll relapse and have to undergo treatment again. This fear is normal but awful to...

Over the years, various classification systems have been used to differentiate lymphoma types including the Rappaport Classification (used until...

If you are new to this website or are looking for guidance to a specific page, here is a list of links to articles that can help you. The "Main...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Advances in the treatment of Hodgkin's lymphoma have resulted in remarkable survival rates, even for...